Clopidogrel Pharmacogenomics
Links shared publicly online about this topic.
- 2,333total visits
Clopidogrel Pharmacogenomics
View full resource at blogs.theheart.org
Tags: Anti-Clotting Medication, Plavix, Iscover
Most Recently Shared on January 14, 2009 at 1:31 am By:
From theheart.org bl Clopidogrel Pharmacogenomics: 3 new studies, 2 in the New England J of .. http://tinyurl.com/7f3nz6
AssureRx Health Launches Personalized Medicine Test for ADHD | Highlight HEALTH 2.0
highlighthealth.org — “The GeneSightRx ADHD pharmacogenomic test is designed to support medication management of patients diagnosed with ADHD.” View full resource at highlighthealth.org
Most Recently Shared on May 8, 2012 at 6:42 am By:
Walter Jessen, PhD Pharma, Research, PhD, Active Health Library, and Doctor
AssureRx Health Launches Personalized Medicine Test for ADHD http://t.co/EQ4LTo2l
AssureRx Health Launches Personalized Medicine Test for ADHD | Highlight HEALTH 2.0
feeds.feedblitz.com — “The GeneSightRx ADHD pharmacogenomic test is designed to support medication management of patients diagnosed with ADHD.” View full resource at feeds.feedblitz.com
Most Recently Shared on May 8, 2012 at 12:01 am By:
AssureRx introduces new pharmacogenomic test for ADHD
news-medical.net — “AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications.” View full resource at news-medical.net
Most Recently Shared on May 7, 2012 at 1:48 pm By:
AssureRx introduces new pharmacogenomic test for ADHD: AssureRx Health, Inc. today announced it has launched a p... http://t.co/OkElon0L
AssureRx Health Launches Personalized Medicine Test for ADHD | Biomarker Commons
feeds.feedblitz.com — “AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD).” View full resource at feeds.feedblitz.com
Most Recently Shared on May 7, 2012 at 10:07 am By:
Putting Pharmacogenomics into Practice Strategies for Successful Implementation
www2.gotomeeting.com — “Leslie Mackowiak, RPh, MS will briefly introduce pharmacogenomics and some standard terminology. She will then review the experience of the pharmacists in supporting the practical application of pharmacogenomics into clinical practice using computer tools. This will involve describing the role of electronic health records and clinical decision support in facilitating drug management using pharmacogenomics. She will identify strategies and techniques for pharmacists to lead the introducti” View full resource at www2.gotomeeting.com
Most Recently Shared on April 4, 2012 at 3:18 pm By:
Our webinar on April 18 will go over how to successfully implement pharmacogenomics into your clinical practice:... http://t.co/HqLqyC8i
PGx Highlights from American College of Cardiology Annual Meeting | Pharmacogenomics Reporter | MDx | GenomeWeb
genomeweb.com — “PGx Highlights from American College of Cardiology Annual Meeting | Pharmacogenomics Reporter | MDx | GenomeWeb” View full resource at genomeweb.com
Most Recently Shared on March 29, 2012 at 5:43 pm By:
PGx Highlights from American College of Cardiology Annual Meeting: The annual meeting of the American College of... http://t.co/LMG2FlxV
Proof-of-Concept for Bedside Rapid Genotyping Test of CYP2C19 - Forbes
forbes.com — “A new point-of-care test can rapidly identify people with a common genetic variant associated with impaired clopidogrel function. The authors claim that this is the first study to demonstrate the feasibility of delivering a genetic test at bedside. In an article published online in the Lancet, Jason Roberts and colleagues report on a new [...]” View full resource at forbes.com
Most Recently Shared on March 29, 2012 at 1:24 am By:
Luis Saldana Doctor, Emergency Physician, and Physician
Forbes: Proof-of-Concept for Bedside Rapid Genotyping Test of CYP2C19 http://t.co/7QVzC6QR
Proof-of-Concept for Bedside Rapid Genotyping Test of CYP2C19 - Forbes
forbes.com — “A new point-of-care test can rapidly identify people with a common genetic variant associated with impaired clopidogrel function. The authors claim that this is the first study to demonstrate the feasibility of delivering a genetic test at bedside. In an article published online in the Lancet, Jason Roberts and colleagues report on a new [...]” View full resource at forbes.com
Most Recently Shared on March 29, 2012 at 12:08 am By:
Drugs and Devices OW OW Health
Proof-of-Concept for Bedside Rapid Genotyping Test of CYP2C19: A new point-of-care test can rapidly identi... http://t.co/x1b8y6zi #drug
Endocrinology News - Phase II Efficacy and Pharmacogenomic Study of Selumetinib in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements |3993684
mdlinx.com — “Endocrinology Medical Article: Phase II Efficacy and Pharmacogenomic Study of Selumetinib in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements” View full resource at mdlinx.com
Most Recently Shared on March 26, 2012 at 9:52 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II Efficacy and Pharmacogenomic Study of Selumetinib in Iodine-131 Refractory Papillary Thyroid Carc... http://t.co/YE1WW8Af #endo
New Data Suggests Results of PLATO Genetic Sub-Study Outcomes for BRILINTA® (Ticagrelor) Not Driven by Poor Metabolizers of Clopidogrel - Drugs.com MedNews
drugs.com — “Mar 25, 2012 - AstraZeneca (NYSE AZN) today announced results from a sub-analysis of the PLATO genetic sub-study that evaluated the impact of poor metabolizers” View full resource at drugs.com
Most Recently Shared on March 26, 2012 at 12:06 pm By:
Drugs and Devices OW OW Health
New Data Suggests Results of PLATO Genetic Sub-Study Outcomes for BRILINTA® (Ticagrelor) Not Driven by Poo... http://t.co/9lkOsga9 #drug
New Data Suggests BRILINTA (ticagrelor) Reduced First and Recurrent Cardiovascular and Ischemic Events - Drugs.com MedNews
drugs.com — “PLATO sub-analysis on the effects of BRILINTA versus clopidogrel for second events, including urgent revascularization, recurrent ischemia, transient ischemic a” View full resource at drugs.com
Most Recently Shared on March 26, 2012 at 12:06 pm By:
Drugs and Devices OW OW Health
New Data Suggests BRILINTA (ticagrelor) Reduced First and Recurrent Cardiovascular and Ischemic Events: PL... http://t.co/hnoV1man #drug
Prasugrel Bests Double-Dose Clopidogrel in Clopidogrel Nonresponders : Cardiology News
ecardiologynews.com — “Cardiology News is an independent news source that provides cardiologists with timely and relevant news and commentary about clinical developments and the impact of health care policy on cardiology and the cardiologist's practice. Cardiology News Digital Network is the online destination and multimedia properties of Cardiology News, the independent news publication for cardiologists. Cardiology news is the leading source of news and commentary about clinical developments in cardiology as well as” View full resource at ecardiologynews.com
Most Recently Shared on March 25, 2012 at 4:34 pm By:
Bob Finn - Medical News Net Health News
Patients on clopidogrel for stable coronary disease benefit more from switching to prasugrel than doubling the dose - http://t.co/96ca10hr
TRA 2ºP-TIMI 50 (vorapaxar): Are we any closer to improving on clopidogrel post-ACS?
blogs.theheart.org — “TRA 2ºP-TIMI 50, released here in Chicago, showed that adding a third agent (vorapaxar) to an antiplatelet regimen post-ACS causes a reduction in ischemic events that's counterbalanced by increased bleeding.” View full resource at blogs.theheart.org
Most Recently Shared on March 24, 2012 at 1:16 pm By:
#ACC12 TRA 2ºP-TIMI 50 (vorapaxar): Are we any closer to improving on clopidogrel post-ACS? http://t.co/Lk2R0o9E
People in the News: David Botstein, Eric Lander, Craig Venter | Pharmacogenomics Reporter | MDx | GenomeWeb
genomeweb.com — “People in the News: David Botstein, Eric Lander, Craig Venter | Pharmacogenomics Reporter | MDx | GenomeWeb” View full resource at genomeweb.com
Most Recently Shared on March 21, 2012 at 7:32 pm By:
westr Doctor, Health Social Media, and PhD
David Botstein, Eric Lander, and Craig Venter will share the 2012 Dan David Prize: http://t.co/AFx9O6rP #pm101
Endocrinology News - Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study |3987433
mdlinx.com — “Endocrinology Medical Article: Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study” View full resource at mdlinx.com
Most Recently Shared on March 20, 2012 at 1:16 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes ... http://t.co/zBALlWto #endo
Advertisement
